Ikarian Capital, LLC 13D and 13G filings for Traws Pharma, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-05-15 5:26 pm Purchase | 2025-03-31 | 13G | Traws Pharma, Inc. TRAW | Ikarian Capital, LLC | 589,502 9.990% | 195,247 (+49.52%) | Filing |
| 2025-02-14 1:18 pm Purchase | 2024-12-31 | 13G | Traws Pharma, Inc. TRAW | Ikarian Capital, LLC | 394,255 9.990% | 394,255 (New Position) | Filing |